B. Safsten et al., CHOLINERGIC INFLUENCE ON DUODENAL MUCOSAL BICARBONATE SECRETION IN THE ANESTHETIZED RAT, The American journal of physiology, 267(1), 1994, pp. 70000010-70000017
Bicarbonate secretion by duodenum distal to the Brunner's glands area
was titrated in situ in rats anesthetized with thiobarbiturate. The un
selective muscarinic antagonist atropine (0.4 mg/kg) inhibited secreti
on stimulated by bethanechol (15 mu g.kg(-1).h(-1)) but not that stimu
lated by carbachol (15 mu g.kg(-1).h(-1)). The nicotinic antagonist he
xamethonium (10 mg.kg(-1).h(-1)), however, abolished the latter respon
se. The muscarinic M(1)-selective antagonists pirenzepine and telenzep
ine (0.025, 0.25 and 2.5 mg/kg) did not decrease but caused a dose-dep
endent rise in duodenal mucosal HCO3- secretion, an effect abolished b
y cervical vagotomy or infusion of the alpha-adrenoceptor antagonist p
hentolamine (0.1 mg.kg(-1).h(-1)). Phentolamine alone caused a sustain
ed increase in secretion. McN-A-343 (0.025, 0.25, and 2.5 mg/kg), an M
(1)-selective agonist and ganglionic stimulator, increased the HCO3- s
ecretion; this effect was not prevented by vagotomy but was attenuated
by pirenzepine. Intracerebroventricular infusion of pirenzepine and t
elenzepine did not cause any changes in secretion. These findings sugg
est that peripheral muscarinic M(1) and nicotinic receptors mediate ch
olinergic stimulation of duodenal mucosal HCO3- secretion. Pirenzepine
and telenzepine may act stimulatory by antagonizing muscarinic M(1)-t
ransmission in peripheral sympathetic ganglia, thus decreasing postsyn
aptic adrenergic inhibition.